This embryonic gene may help fight ageing

Image
IANS New York
Last Updated : Jul 26 2016 | 2:22 PM IST

The fountain of youth may reside in an embryonic stem cell gene named Nanog, suggests new research that may lead to treatments for conditions due to reduced bone strength, Alzheimer's and other age-related disorders.

In a series of experiments at the University at Buffalo in New York, the gene kicked into action dormant cellular processes that are key to preventing weak bones, clogged arteries and other telltale signs of growing old.

"Our research into Nanog is helping us to better understand the process of ageing and ultimately how to reverse it," said the study's lead author Stelios Andreadis, Professor at the University at Buffalo School of Engineering and Applied Sciences.

The findings, published in the journal Stem Cells, also showed promise in counteracting premature ageing disorders such as Hutchinson-Gilford progeria syndrome.

To battle ageing, the human body holds a reservoir of non-specialised cells that can regenerate organs.

These cells are called adult stem cells, and they are located in every tissue of the body and respond rapidly when there is a need.

But as people age, fewer adult stem cells perform their job well, a scenario which leads to age-related disorders.

Reversing the effects of ageing on adult stem cells, essentially rebooting them, can help overcome this problem.

In the new study, Panagiotis Mistriotis, a graduate student in Andreadis' lab and first author of the study, introduced Nanog into aged stem cells.

He found that Nanog opens two key cellular pathways that jumpstarts dormant proteins into building cytoskeletons that adult stem cells need to form muscle cells that contract.

Force generated by these cells ultimately helps restore the regenerative properties that adult stem cells lose due to ageing.

"Not only does Nanog have the capacity to delay aging, it has the potential in some cases to reverse it," Andreadis said.

The researchers are now focusing on identifying drugs that can replace or mimic the effects of Nanog. This will allow them to study whether aspects of aging inside the body can also be reversed.

--IANS

gb/bg

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 26 2016 | 2:10 PM IST

Next Story